Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Fifty years on: Serotonin and depression

Jauhar S. et al, (2023), Journal of Psychopharmacology

Stimulating human prefrontal cortex increases reward learning.

Overman MJ. et al, (2023), Neuroimage

Brain activity measured by functional brain imaging predicts breathlessness improvement during pulmonary rehabilitation.

Finnegan SL. et al, (2022), Thorax

Setting national research priorities for Difficult-to-Treat Depression in the UK between 2021-2026

Chapman N. et al, (2022), Journal of Global Health

Using a generative model of affect to characterize affective variability and its response to treatment in bipolar disorder.

Pulcu E. et al, (2022), Proc Natl Acad Sci U S A, 119

What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?

Lan D. and BROWNING M., (2022), Computational Psychiatry

Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers.

Kaltenboeck A. et al, (2022), Int J Neuropsychopharmacol

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Au-Yeung SK. et al, (2022), Evid Based Ment Health, 25, 77 - 83

Dynamic modulation of inequality aversion in human interpersonal negotiations.

Murphy DAJ. et al, (2022), Commun Biol, 5

Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study.

Baião R. et al, (2022), Psychol Med, 1 - 11

Emotional cognition in depression: Is it relevant for Clinical practice?

Harmer CJ. and Browning M., (2021), Eur Neuropsychopharmacol, 56, 1 - 3

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease

Brown AJH. et al, (2021), Cell, 184, 5886 - 5901.e22

A Computational View on the Nature of Reward and Value in Anhedonia

huys Q. and BROWNING M., (2021), Current topics in behavioral neurosciences

When Helping Is Risky: The Behavioral and Neurobiological Trade-off of Social and Risk Preferences.

Gross J. et al, (2021), Psychol Sci, 32, 1842 - 1855

When Helping Is Risky: The Behavioral and Neurobiological Trade-off of Social and Risk Preferences.

Gross J. et al, (2021), Psychol Sci

Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment.

Dawson GR. et al, (2021), J Psychopharmacol

An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers.

Martens MAG. et al, (2021), Pharmaceuticals (Basel), 14

The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial.

Browning M. et al, (2021), Neuropsychopharmacology, 46, 1307 - 1314

How Representative are Neuroimaging Samples? Large-Scale Evidence for Trait Anxiety Differences Between fMRI and Behaviour-Only Research Participants.

Charpentier CJ. et al, (2021), Soc Cogn Affect Neurosci

Measuring Mood Instability Using a Generative Model of Affect

Pulcu E. et al, (2021), BIOLOGICAL PSYCHIATRY, 89, S113 - S114

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?